Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001641172-25-022815
Filing Date
2025-08-08
Accepted
2025-08-08 17:15:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a.htm DEFA14A 11464
2 GRAPHIC proxy_001.jpg GRAPHIC 428530
3 GRAPHIC proxy_002.jpg GRAPHIC 512650
4 GRAPHIC proxy_003.jpg GRAPHIC 287817
  Complete submission text file 0001641172-25-022815.txt   1705457
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: DEFA14A | Act: 34 | File No.: 001-41765 | Film No.: 251199416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)